1932

Abstract

Alcohol consumption has long been a part of human culture. However, alcohol consumption levels and alcohol consumption patterns are associated with chronic diseases. Overall, light and moderate alcohol consumption (up to 14 g per day for women and up to 28 g per day for men) may be associated with reduced mortality risk, mainly due to reduced risks for cardiovascular disease and type-2 diabetes. However, chronic heavy alcohol consumption and alcohol abuse lead to alcohol-use disorder, which results in physical and mental diseases such as liver disease, pancreatitis, dementia, and various types of cancer. Risk factors for alcohol-use disorder are largely unknown. Alcohol-use disorder and frequent heavy drinking have detrimental effects on personal health.

Loading

Article metrics loading...

/content/journals/10.1146/annurev-food-032519-051827
2020-03-25
2024-06-17
Loading full text...

Full text loading...

/deliver/fulltext/food/11/1/annurev-food-032519-051827.html?itemId=/content/journals/10.1146/annurev-food-032519-051827&mimeType=html&fmt=ahah

Literature Cited

  1. Abat C, Roussel Y, Chaudet H, Raoult D 2019. Alcohol and the global burden of disease. Lancet 393:2390–91
    [Google Scholar]
  2. Abbasi A, Sahlqvist AS, Lotta L, Brosnan JM, Vollenweider P et al. 2016. A systematic review of biomarkers and risk of incident type 2 diabetes: an overview of epidemiological, prediction and aetiological research literature. PLOS ONE 11:e0163721
    [Google Scholar]
  3. Am. Psychiatr. Assoc. (APA) 2013. Diagnostic and Statistical Manual of Mental Disorders Washington, DC: APA. , 5th ed..
    [Google Scholar]
  4. Andrews MM, Meda SA, Thomas AD, Potenza MN, Krystal JH et al. 2011. Individuals family history positive for alcoholism show functional magnetic resonance imaging differences in reward sensitivity that are related to impulsivity factors. Biol. Psychiatry 69:675–83
    [Google Scholar]
  5. Anstey KJ, Mack HA, Cherbuin N 2009. Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am. J. Geriatr. Psychiatry 17:542–55
    [Google Scholar]
  6. Arteaga CL, Adamson PC, Engelman JA, Foti M, Gaynor RB et al. 2014. AACR cancer progress report 2014. Clin. Cancer Res. 20:S1–112
    [Google Scholar]
  7. Astrup A, Costanzo S, de Gaetano G 2018. Risk thresholds for alcohol consumption. Lancet 392:2165–66
    [Google Scholar]
  8. Astrup A, Estruch R. 2019. Alcohol and the global burden of disease. Lancet 393:P2390
    [Google Scholar]
  9. Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F et al. 2013. Light alcohol drinking and cancer: a meta-analysis. Ann. Oncol. 24:301–8
    [Google Scholar]
  10. Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F et al. 2015. Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br. J. Cancer 112:580–93
    [Google Scholar]
  11. Baliunas DO, Taylor BJ, Irving H, Roerecke M, Patra J et al. 2009. Alcohol as a risk factor for type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 32:2123–32
    [Google Scholar]
  12. Berkel TD, Pandey SC. 2017. Emerging role of epigenetic mechanisms in alcohol addiction. Alcohol. Clin. Exp. Res. 41:666–80
    [Google Scholar]
  13. Beulens JW, van der Schouw YT, Bergmann MM, Rohrmann S, Schulze MB et al. 2012. Alcohol consumption and risk of type 2 diabetes in European men and women: influence of beverage type and body size. The EPIC–InterAct study. J. Intern. Med. 272:358–70
    [Google Scholar]
  14. Beulens JW, van Loon LJ, Kok FJ, Pelsers M, Bobbert T et al. 2007. The effect of moderate alcohol consumption on adiponectin oligomers and muscle oxidative capacity: a human intervention study. Diabetologia 50:1388–92
    [Google Scholar]
  15. Bhupathiraju SN, Hu FB. 2016. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ. Res. 118:1723–35
    [Google Scholar]
  16. Brányik T, Silva DP, Baszczynski M, Lehnert R, Almeida e Silva JB 2012. A review of methods of low alcohol and alcohol-free beer production. J. Food Eng. 108:493–506
    [Google Scholar]
  17. Briasoulis A, Agarwal V, Messerli FH 2012. Alcohol consumption and the risk of hypertension in men and women: a systematic review and meta-analysis. J. Clin. Hypertens. 14:792–98
    [Google Scholar]
  18. Brites F, Martin M, Guillas I, Kontush A 2017. Antioxidative activity of high-density lipoprotein (HDL): mechanistic insights into potential clinical benefit. BBA Clin 8:66–77
    [Google Scholar]
  19. Brooks PJ, Zakhari S. 2013. Moderate alcohol consumption and breast cancer in women: from epidemiology to mechanisms and interventions. Alcohol. Clin. Exp. Res. 37:23–30
    [Google Scholar]
  20. Cai S, Li Y, Ding Y, Chen K, Jin M 2014. Alcohol drinking and the risk of colorectal cancer death: a meta-analysis. Eur. J. Cancer Prev. 23:532–39
    [Google Scholar]
  21. Carrigan MA, Uryasev O, Davis RP, Zhai L, Hurley TD, Benner SA 2012. The natural history of class I primate alcohol dehydrogenases includes gene duplication, gene loss, and gene conversion. PLOS ONE 7:e41175
    [Google Scholar]
  22. Cederbaum AI. 2012. Alcohol metabolism. Clin. Liver Dis. 16:667–85
    [Google Scholar]
  23. Ceni E, Mello T, Galli A 2014. Pathogenesis of alcoholic liver disease: role of oxidative metabolism. World J. Gastroenterol. 20:17756–72
    [Google Scholar]
  24. Cheng C, Huang CL, Tsai CJ, Chou PH, Lin CC, Chang CK 2017. Alcohol-related dementia: a systemic review of epidemiological studies. Psychosomatics 58:331–42
    [Google Scholar]
  25. Claus ED, Ewing SW, Filbey FM, Sabbineni A, Hutchison KE 2011. Identifying neurobiological phenotypes associated with alcohol use disorder severity. Neuropsychopharmacology 36:2086–96
    [Google Scholar]
  26. Comporti M, Signorini C, Leoncini S, Gardi C, Ciccoli L et al. 2010. Ethanol-induced oxidative stress: basic knowledge. Genes Nutr 5:101–9
    [Google Scholar]
  27. Cornelius J, Kirisci L, Reynolds M, Tarter R 2014. Does stress mediate the development of substance use disorders among youth transitioning to young adulthood?. Am. J. Drug Alcohol Abuse 40:225–29
    [Google Scholar]
  28. Costin BN, Miles MF. 2014. Molecular and neurologic responses to chronic alcohol use. Handb. Clin. Neurol. 125:157–71
    [Google Scholar]
  29. Dasarathy S. 2016. Nutrition and alcoholic liver disease: effects of alcoholism on nutrition, effects of nutrition on alcoholic liver disease, and nutritional therapies for alcoholic liver disease. Clin. Liver Dis. 20:535–50
    [Google Scholar]
  30. Dep. Health Human Serv. (DHHS) 2018. Dietary guidelines 2015–2020. Appendix 9. Alcohol Washington, DC: DHHS https://health.gov/dietaryguidelines/2015/guidelines/appendix-9/
  31. Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, de Gaetano G 2006. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch. Intern. Med. 166:2437–45
    [Google Scholar]
  32. Di Castelnuovo AF, Costanzo S, de Gaetano G 2019. Alcohol and the global burden of disease. Lancet 393:2389
    [Google Scholar]
  33. Edenberg HJ. 2007. The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res. Health 30:5–13
    [Google Scholar]
  34. Enoch MA. 2006. Genetic and environmental influences on the development of alcoholism: resilience versus risk. Ann. N. Y. Acad. Sci. 1094:193–201
    [Google Scholar]
  35. Enoch MA. 2011. The role of early life stress as a predictor for alcohol and drug dependence. Psychopharmacology 214:17–31
    [Google Scholar]
  36. Ewing JA. 1984. Detecting alcoholism. The CAGE questionnaire. JAMA 252:1905–7
    [Google Scholar]
  37. Fedirko V, Tramacere I, Bagnardi V, Rota M, Scotti L et al. 2011. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann. Oncol. 22:1958–72
    [Google Scholar]
  38. Fehringer G, Brenner DR, Zhang ZF, Lee YA, Matsuo K et al. 2017. Alcohol and lung cancer risk among never smokers: a pooled analysis from the International Lung Cancer Consortium and the SYNERGY study. Int. J. Cancer 140:91976–84
    [Google Scholar]
  39. Femlak M, Gluba-Brzozka A, Cialkowska-Rysz A, Rysz J 2017. The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk. Lipids Health Dis 16:207
    [Google Scholar]
  40. Fernandes I, Perez-Gregorio R, Soares S, Mateus N, de Freitas V 2017. Wine flavonoids in health and disease prevention. Molecules 22:2292
    [Google Scholar]
  41. Ferrari P, Jenab M, Norat T, Moskal A, Slimani N et al. 2007. Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int. J. Cancer 121:2065–72
    [Google Scholar]
  42. Ferrari P, Licaj I, Muller DC, Kragh Andersen P, Johansson M et al. 2014. Lifetime alcohol use and overall and cause-specific mortality in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. BMJ Open 4:e005245
    [Google Scholar]
  43. Fillmore KM, Stockwell T, Chikritzhs T, Bostrom A, Kerr W 2007. Moderate alcohol use and reduced mortality risk: systematic error in prospective studies and new hypotheses. Ann. Epidemiol. 17:S16–23
    [Google Scholar]
  44. Gastfriend DR. 2014. A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disorders. Ann. N. Y. Acad. Sci. 1327:112–30
    [Google Scholar]
  45. GBD 2016 Alcohol Collab 2018. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 392:1015–35
    [Google Scholar]
  46. GBD 2016 Causes Death Collab 2017. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390:1151–210
    [Google Scholar]
  47. Grant BF, Goldstein RB, Saha TD, Chou SP, Jung J et al. 2015. Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry 72:757–66
    [Google Scholar]
  48. Greenfield TK. 2016. The importance of methodological meta-analyses and a call to assess current and former drinking patterns: a commentary on Stockwell et al. 2016. J. Stud. Alcohol Drugs 77:199–200
    [Google Scholar]
  49. Halsted CH. 2013. B-Vitamin dependent methionine metabolism and alcoholic liver disease. Clin. Chem. Lab. Med. 51:457–65
    [Google Scholar]
  50. Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE et al. 2002. Alcohol, tobacco and breast cancer: collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br. J. Cancer 87:1234–45
    [Google Scholar]
  51. Heier C, Xie H, Zimmermann R 2016. Nonoxidative ethanol metabolism in humans: from biomarkers to bioactive lipids. IUBMB Life 68:916–23
    [Google Scholar]
  52. Hendriks HF, Veenstra J, van Tol A, Groener JE, Schaafsma G 1998. Moderate doses of alcoholic beverages with dinner and postprandial high density lipoprotein composition. Alcohol Alcohol 33:403–10
    [Google Scholar]
  53. Hendriks HF, Veenstra J, Velthuis-te Wierik EJ, Schaafsma G, Kluft C 1994. Effect of moderate dose of alcohol with evening meal on fibrinolytic factors. BMJ 308:1003–6
    [Google Scholar]
  54. Hoyme HE, Kalberg WO, Elliott AJ, Blankenship J, Buckley D et al. 2016. Updated clinical guidelines for diagnosing fetal alcohol spectrum disorders. Pediatrics 138:e20154256
    [Google Scholar]
  55. Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett WC et al. 2001. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch. Intern. Med. 161:1717–23
    [Google Scholar]
  56. Ijaz S, Jackson J, Thorley H, Porter K, Fleming C et al. 2017. Nutritional deficiencies in homeless persons with problematic drinking: a systematic review. Int. J. Equity Health 16:71
    [Google Scholar]
  57. Islami F, Fedirko V, Tramacere I, Bagnardi V, Jenab M et al. 2011. Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: a systematic review and meta-analysis. Int. J. Cancer 129:2473–84
    [Google Scholar]
  58. Jayasekara H, English DR, Room R, MacInnis RJ 2014. Alcohol consumption over time and risk of death: a systematic review and meta-analysis. Am. J. Epidemiol. 179:1049–59
    [Google Scholar]
  59. Jones L, Bates G, McCoy E, Bellis MA 2015. Relationship between alcohol-attributable disease and socioeconomic status, and the role of alcohol consumption in this relationship: a systematic review and meta-analysis. BMC Public Health 15:400
    [Google Scholar]
  60. Joosten MM, Beulens JW, Kersten S, Hendriks HF 2008. Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: a randomised, crossover trial. Diabetologia 51:1375–81
    [Google Scholar]
  61. Joosten MM, Schrieks IC, Hendriks HF 2014. Effect of moderate alcohol consumption on fetuin-A levels in men and women: post-hoc analyses of three open-label randomized crossover trials. Diabetol. Metab. Syndr. 6:24
    [Google Scholar]
  62. Keene D, Price C, Shun-Shin MJ, Francis DP 2014. Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients. BMJ 349:g4379
    [Google Scholar]
  63. Kerr J, Anderson C, Lippman SM 2017. Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence. Lancet Oncol 18:e457–71
    [Google Scholar]
  64. King H, Aubert RE, Herman WH 1998. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–31
    [Google Scholar]
  65. Klarich DS, Brasser SM, Hong MY 2015. Moderate alcohol consumption and colorectal cancer risk. Alcohol. Clin. Exp. Res. 39:1280–91
    [Google Scholar]
  66. Klatsky AL. 2015. Alcohol and cardiovascular diseases: Where do we stand today. ? J. Intern. Med. 278:238–50
    [Google Scholar]
  67. Knott C, Bell S, Britton A 2015. Alcohol consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of more than 1.9 million individuals from 38 observational studies. Diabetes Care 38:1804–12
    [Google Scholar]
  68. Koppes LL, Dekker JM, Hendriks HF, Bouter LM, Heine RJ 2005. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care 28:719–25
    [Google Scholar]
  69. Koppes LL, Dekker JM, Hendriks HF, Bouter LM, Heine RJ 2006. Meta-analysis of the relationship between alcohol consumption and coronary heart disease and mortality in type 2 diabetic patients. Diabetologia 49:648–52
    [Google Scholar]
  70. Koskinen J, Lohonen J, Koponen H, Isohanni M, Miettunen J 2009. Prevalence of alcohol use disorders in schizophrenia: a systematic review and meta-analysis. Acta Psychiatr. Scand. 120:85–96
    [Google Scholar]
  71. Lai HM, Cleary M, Sitharthan T, Hunt GE 2015. Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: a systematic review and meta-analysis. Drug Alcohol Depend 154:1–13
    [Google Scholar]
  72. Lange S, Shield K, Rehm J, Popova S 2013. Prevalence of fetal alcohol spectrum disorders in child care settings: a meta-analysis. Pediatrics 132:e980–95
    [Google Scholar]
  73. Laramee P, Leonard S, Buchanan-Hughes A, Warnakula S, Daeppen JB, Rehm J 2015. Risk of all-cause mortality in alcohol-dependent individuals: a systematic literature review and meta-analysis. EBioMedicine 2:1394–404
    [Google Scholar]
  74. Larsson SC, Drca N, Wolk A 2014. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J. Am. Coll. Cardiol. 64:281–89
    [Google Scholar]
  75. Larsson SC, Orsini N, Wolk A 2015. Alcohol consumption and risk of heart failure: a dose-response meta-analysis of prospective studies. Eur. J. Heart Fail. 17:367–73
    [Google Scholar]
  76. Larsson SC, Wallin A, Wolk A, Markus HS 2016. Differing association of alcohol consumption with different stroke types: a systematic review and meta-analysis. BMC Med 14:178
    [Google Scholar]
  77. Lee SL, Chau GY, Yao CT, Wu CW, Yin SJ 2006. Functional assessment of human alcohol dehydrogenase family in ethanol metabolism: significance of first-pass metabolism. Alcohol. Clin. Exp. Res. 30:1132–42
    [Google Scholar]
  78. Leeman RF, Beseler CL, Helms CM, Patock-Peckham JA, Wakeling VA, Kahler CW 2014. A brief, critical review of research on impaired control over alcohol use and suggestions for future studies. Alcohol. Clin. Exp. Res. 38:301–8
    [Google Scholar]
  79. Levitsky J, Mailliard ME. 2004. Diagnosis and therapy of alcoholic liver disease. Semin. Liver Dis. 24:233–47
    [Google Scholar]
  80. Ley SH, Sun Q, Jimenez MC, Rexrode KM, Manson JE et al. 2014. Association between alcohol consumption and plasma fetuin-A and its contribution to incident type 2 diabetes in women. Diabetologia 57:93–101
    [Google Scholar]
  81. Li X-H, Yu F-F, Zhou Y-H, He J 2016. Association between alcohol consumption and the risk of incident type 2 diabetes: a systematic review and dose-response meta-analysis. Am. J. Clin. Nutr. 103:818–29
    [Google Scholar]
  82. Lieb R, Merikangas KR, Hofler M, Pfister H, Isensee B, Wittchen HU 2002. Parental alcohol use disorders and alcohol use and disorders in offspring: a community study. Psychol. Med. 32:63–78
    [Google Scholar]
  83. Mann RE, Smart RG, Govoni R 2003. The epidemiology of alcoholic liver disease. Alcohol Res. Health 27:209–19
    [Google Scholar]
  84. Marshall ME. 1979. Beliefs, Behaviors, and Alcoholic Beverages: A Cross-Cultural Survey Ann Arbor: Univ. Mich. Press
    [Google Scholar]
  85. Martin PR, Singleton CK, Hiller-Sturmhofel S 2003. The role of thiamine deficiency in alcoholic brain disease. Alcohol Res. Health 27:134–42
    [Google Scholar]
  86. Mayfield RD, Harris RA, Schuckit MA 2008. Genetic factors influencing alcohol dependence. Br. J. Pharmacol. 154:275–87
    [Google Scholar]
  87. McGovern PE, Zhang J, Tang J, Zhang Z, Hall GR et al. 2004. Fermented beverages of pre- and proto-historic China. PNAS 101:17593–98
    [Google Scholar]
  88. Mitchell AJ, Bird V, Rizzo M, Hussain S, Meader N 2014. Accuracy of one or two simple questions to identify alcohol-use disorder in primary care: a meta-analysis. Br. J. Gen. Pract. 64:e408–18
    [Google Scholar]
  89. Molina PE, Gardner JD, Souza-Smith FM, Whitaker AM 2014. Alcohol abuse: critical pathophysiological processes and contribution to disease burden. Physiology 29:203–15
    [Google Scholar]
  90. Moshage H, Casini A, Lieber CS 1990. Acetaldehyde selectively stimulates collagen production in cultured rat liver fat-storing cells but not in hepatocytes. Hepatology 12:511–18
    [Google Scholar]
  91. Mostofsky E, Chahal HS, Mukamal KJ, Rimm EB, Mittleman MA 2016. Alcohol and immediate risk of cardiovascular events: a systematic review and dose-response meta-analysis. Circulation 133:979–87
    [Google Scholar]
  92. Mukamal KJ, Clowry CM, Murray MM, Hendriks HF, Rimm EB et al. 2016. Moderate alcohol consumption and chronic disease: the case for a long-term trial. Alcohol. Clin. Exp. Res. 40:2283–91
    [Google Scholar]
  93. Mukamal KJ, Conigrave KM, Mittleman MA, Camargo CA Jr, Stampfer MJ et al. 2003. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. New Engl. J. Med. 348:109–18
    [Google Scholar]
  94. Mukamal KJ, Jensen MK, Gronbaek M, Stampfer MJ, Manson JE et al. 2005. Drinking frequency, mediating biomarkers, and risk of myocardial infarction in women and men. Circulation 112:1406–13
    [Google Scholar]
  95. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC 1997. Excess weight risk factor for alcoholic liver disease. Hepatology 25:108–11
    [Google Scholar]
  96. Niemela O. 2016. Biomarker-based approaches for assessing alcohol use disorders. Int. J. Environ. Res. Public Health 13:166
    [Google Scholar]
  97. Patra J, Taylor B, Irving H, Roerecke M, Baliunas D et al. 2010. Alcohol consumption and the risk of morbidity and mortality for different stroke types: a systematic review and meta-analysis. BMC Public Health 10:258
    [Google Scholar]
  98. Pearson MR, Kirouac M, Witkiewitz K 2016. Questioning the validity of the 4+/5+ binge or heavy drinking criterion in college and clinical populations. Addiction 111:1720–26
    [Google Scholar]
  99. Peters R, Peters J, Warner J, Beckett N, Bulpitt C 2008. Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing 37:505–12
    [Google Scholar]
  100. Pikaar NA, Wedel M, Hermus RJ 1988. Influence of several factors on blood alcohol concentrations after drinking alcohol. Alcohol Alcohol 23:289–97
    [Google Scholar]
  101. Poikolainen K. 2008. The magic to make the “preventive effect” of alcohol disappear and reappear. Addiction 103:1905; author reply 1905–7
    [Google Scholar]
  102. Pownall HJ, Gotto AM Jr 2016. New insights into the high-density lipoprotein dilemma. Trends Endocrinol. Metab. 27:44–53
    [Google Scholar]
  103. Pownall HJ, Rosales C, Gillard BK, Gotto AM Jr 2015. Alcohol: a nutrient with multiple salutary effects. Nutrients 7:1992–2000
    [Google Scholar]
  104. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP 2013. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 9:63–75
    [Google Scholar]
  105. Rehm J, Samokhvalov AV, Shield KD 2013. Global burden of alcoholic liver diseases. J. Hepatol. 59:160–68
    [Google Scholar]
  106. Renaud S, de Lorgeril M 1992. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339:1523–26
    [Google Scholar]
  107. Restrepo RJ, Lim RW, Korthuis RJ, Shukla SD 2017. Binge alcohol alters PNPLA3 levels in liver through epigenetic mechanism involving histone H3 acetylation. Alcohol 60:77–82
    [Google Scholar]
  108. Roerecke M, Rehm J. 2010. Irregular heavy drinking occasions and risk of ischemic heart disease: a systematic review and meta-analysis. Am. J. Epidemiol. 171:633–44
    [Google Scholar]
  109. Rohatgi A, Khera A, Berry JD, Givens EG, Ayers CR et al. 2014. HDL cholesterol efflux capacity and incident cardiovascular events. New Engl. J. Med. 371:2383–93
    [Google Scholar]
  110. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA 2011. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ 342:d671
    [Google Scholar]
  111. Rosenson RS. 2016. The high-density lipoprotein puzzle: why classic epidemiology, genetic epidemiology, and clinical trials conflict?. Arterioscler. Thromb. Vasc. Biol. 36:777–82
    [Google Scholar]
  112. Samokhvalov AV, Rehm J, Roerecke M 2015. Alcohol consumption as a risk factor for acute and chronic pancreatitis: a systematic review and a series of meta-analyses. EBioMedicine 2:1996–2002
    [Google Scholar]
  113. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M 1993. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption–II. Addiction 88:791–804
    [Google Scholar]
  114. Schernhammer E. 2018. Risk thresholds for alcohol consumption. Lancet 392:2166–67
    [Google Scholar]
  115. Schrieks IC, Heil AL, Hendriks HF, Mukamal KJ, Beulens JW 2015. The effect of alcohol consumption on insulin sensitivity and glycemic status: a systematic review and meta-analysis of intervention studies. Diabetes Care 38:723–32
    [Google Scholar]
  116. Schuebel K, Gitik M, Domschke K, Goldman D 2016. Making sense of epigenetics. Int. J. Neuropsychopharmacol. 19:11pyw058
    [Google Scholar]
  117. Seitz HK. 2006. Additive effects of moderate drinking and obesity on serum gamma-glutamyl transferase. Am. J. Clin. Nutr. 83:1252–53
    [Google Scholar]
  118. Seneviratne C, Johnson BA. 2015. Advances in medications and tailoring treatment for alcohol use disorder. Alcohol Res 37:15–28
    [Google Scholar]
  119. Shaper AG, Wannamethee G, Walker M 1988. Alcohol and mortality in British men: explaining the U-shaped curve. Lancet 332:1267–73
    [Google Scholar]
  120. Shield KD, Rehm J. 2019. Alcohol and the global burden of disease. Lancet 393:2390
    [Google Scholar]
  121. Shields AL, Howell RT, Potter JS, Weiss RD 2007. The Michigan Alcoholism Screening Test and its shortened form: a meta-analytic inquiry into score reliability. Subst. Use Misuse 42:1783–800
    [Google Scholar]
  122. Sierksma A, Lebrun CE, van der Schouw YT, Grobbee DE, Lamberts SW et al. 2004a. Alcohol consumption in relation to aortic stiffness and aortic wave reflections: a cross-sectional study in healthy postmenopausal women. Arterioscler. Thromb. Vasc. Biol. 24:342–48
    [Google Scholar]
  123. Sierksma A, Muller M, van der Schouw YT, Grobbee DE, Hendriks HF, Bots ML 2004b. Alcohol consumption and arterial stiffness in men. J. Hypertens. 22:357–62
    [Google Scholar]
  124. Sierksma A, Patel H, Ouchi N, Kihara S, Funahashi T et al. 2004c. Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care 27:184–89
    [Google Scholar]
  125. Sierksma A, van der Gaag MS, Kluft C, Hendriks HF 2002a. Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study. Eur. J. Clin. Nutr. 56:1130–36
    [Google Scholar]
  126. Sierksma A, van der Gaag MS, van Tol A, James RW, Hendriks HF 2002b. Kinetics of HDL cholesterol and paraoxonase activity in moderate alcohol consumers. Alcohol. Clin. Exp. Res. 26:1430–35
    [Google Scholar]
  127. Sierksma A, Vermunt SH, Lankhuizen IM, van der Gaag MS, Scheek LM et al. 2004d. Effect of moderate alcohol consumption on parameters of reverse cholesterol transport in postmenopausal women. Alcohol. Clin. Exp. Res. 28:662–66
    [Google Scholar]
  128. Slade T, Chapman C, Swift W, Keyes K, Tonks Z, Teesson M 2016. Birth cohort trends in the global epidemiology of alcohol use and alcohol-related harms in men and women: systematic review and metaregression. BMJ Open 6:e011827
    [Google Scholar]
  129. Smith-Warner SA, Spiegelman D, Yaun SS, van den Brandt PA, Folsom AR et al. 1998. Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA 279:535–40
    [Google Scholar]
  130. Solomon CG, Hu FB, Stampfer MJ, Colditz GA, Speizer FE et al. 2000. Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus. Circulation 102:494–99
    [Google Scholar]
  131. Stephen Rich J, Martin PR 2014. Co-occurring psychiatric disorders and alcoholism. Handb. Clin. Neurol. 125:573–88
    [Google Scholar]
  132. Stockwell T, Zhao J, Panwar S, Roemer A, Naimi T, Chikritzhs T 2016. Do “moderate” drinkers have reduced mortality risk? A systematic review and meta-analysis of alcohol consumption and all-cause mortality. J. Stud. Alcohol Drugs 77:185–98
    [Google Scholar]
  133. Tariq SM, Sidhu MS, Toth PP, Boden WE 2014. HDL hypothesis: Where do we stand now. ? Curr. Atheroscler. Rep. 16:398
    [Google Scholar]
  134. Tjonneland A, Christensen J, Olsen A, Stripp C, Thomsen BL et al. 2007. Alcohol intake and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control 18:361–73
    [Google Scholar]
  135. Tjonneland A, Gronbaek M, Stripp C, Overvad K 1999. Wine intake and diet in a random sample of 48763 Danish men and women. Am. J. Clin. Nutr. 69:49–54
    [Google Scholar]
  136. Urbano-Marquez A, Estruch R, Navarro-Lopez F, Grau JM, Mont L, Rubin E 1989. The effects of alcoholism on skeletal and cardiac muscle. New Engl. J. Med. 320:409–15
    [Google Scholar]
  137. van der Gaag MS, van Tol A, Scheek LM, James RW, Urgert R et al. 1999. Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men. Atherosclerosis 147:405–10
    [Google Scholar]
  138. van der Gaag MS, van Tol A, Vermunt SH, Scheek LM, Schaafsma G, Hendriks HF 2001. Alcohol consumption stimulates early steps in reverse cholesterol transport. J. Lipid Res. 42:2077–83
    [Google Scholar]
  139. Van Leijenhorst L, Zanolie K, Van Meel CS, Westenberg PM, Rombouts SA, Crone EA 2010. What motivates the adolescent? Brain regions mediating reward sensitivity across adolescence. Cereb. Cortex 20:61–69
    [Google Scholar]
  140. van Tol A, Hendriks HF 2001. Moderate alcohol consumption: effects on lipids and cardiovascular disease risk. Curr. Opin. Lipidol. 12:19–23
    [Google Scholar]
  141. Verges B. 2015. Pathophysiology of diabetic dyslipidaemia: Where are we. ? Diabetologia 58:886–99
    [Google Scholar]
  142. Villafuerte S, Heitzeg MM, Foley S, Yau WY, Majczenko K et al. 2012. Impulsiveness and insula activation during reward anticipation are associated with genetic variants in GABRA2 in a family sample enriched for alcoholism. Mol. Psychiatry 17:511–19
    [Google Scholar]
  143. Weiland BJ, Welsh RC, Yau WY, Zucker RA, Zubieta JK, Heitzeg MM 2013. Accumbens functional connectivity during reward mediates sensation-seeking and alcohol use in high-risk youth. Drug Alcohol Depend 128:130–39
    [Google Scholar]
  144. Whelan R, Watts R, Orr CA, Althoff RR, Artiges E et al. 2014. Neuropsychosocial profiles of current and future adolescent alcohol misusers. Nature 512:185–89
    [Google Scholar]
  145. WHO 2004. Prevalence of alcohol use disorders Rep., World Health Organ Geneva, Switz.:
    [Google Scholar]
  146. WHO 2014. Global status report on alcohol and health–2014 Rep., World Health Organ Geneva, Switz.:
    [Google Scholar]
  147. Wood AM, Kaptoge S, Butterworth AS, Willeit P, Warnakula S et al. 2018. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599912 current drinkers in 83 prospective studies. Lancet 391:1513–23
    [Google Scholar]
  148. Yu E, Rimm E, Qi L, Rexrode K, Albert CM et al. 2016. Diet, lifestyle, biomarkers, genetic factors, and risk of cardiovascular disease in the Nurses’ Health Studies. Am. J. Public Health 106:1616–23
    [Google Scholar]
/content/journals/10.1146/annurev-food-032519-051827
Loading
  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error